title: Cost-effectiveness of Anticipatory and Preventive multidisciplinary Team Care for complex patients: evidence from a randomized controlled trial.
abstract: OBJECTIVE
  To evaluate the cost-effectiveness of Anticipatory and Preventive Team Care (APTCare).
  
  
  METHODS
  Analysis of data drawn from a randomized controlled trial.
  
  
  METHODS
  A family health network in a rural area near Ottawa, Ont.
  
  
  METHODS
  Patients 50 years of age or older at risk of experiencing adverse health outcomes. Analysis of cost-effectiveness was performed for a subsample of participants with at least 1 of the chronic diseases used in the quality of care (QOC) measure (74 intervention and 78 control patients).
  
  
  METHODS
  At-risk patients were randomly assigned to receive usual care from their family physicians or APTCare from a collaborative team.
  
  
  METHODS
  Cost-effectiveness and the net benefit to society of the APTCare intervention.
  
  
  RESULTS
  Costs not directly associated with delivery of the intervention were similar in the 2 arms: $9121 and $9222 for the APTCare and control arms, respectively. Costs directly associated with the program were $3802 per patient for a total cost per patient of $12,923 and $9222, respectively (P=.033). A 1% improvement in QOC was estimated to cost $407 per patient. Analysis of the net benefit to society in absolute dollars found a breakeven threshold of $750 when statistical significance was required. This implies that society must place a value of at least $750 on a 1% improvement in QOC in order for the intervention to be socially worthwhile. By any of the metrics used, the APTCare intervention was not cost-effective, at least not in a population for which baseline QOC was high.
  
  
  CONCLUSIONS
  Although our calculations suggest that the APTCare intervention was not cost-effective, our results need the following caveats. The costs of such a newly introduced intervention are bound to be higher than those for an established, up-and-running program. Furthermore, it is possible that some benefits of the secondary preventive measures were not captured in this limited 12- to 18-month study or were simply not measured. TRIAL REGISTRATION NUMBER NCT00238836 (CONSORT).
authors.affiliation: C.T. Lamont Primary Health Care Research Centre, Elisabeth Bruyère Research Institute, Ottawa, Ontario.
authors.forename: David
authors.initials: D
authors.lastname: Gray
authors.forename: Catherine Deri
authors.initials: CD
authors.lastname: Armstrong
authors.forename: Simone
authors.initials: S
authors.lastname: Dahrouge
authors.forename: William
authors.initials: W
authors.lastname: Hogg
authors.forename: Wei
authors.initials: W
authors.lastname: Zhang
mesh_terms: D000368:Aged; D002908:Chronic Disease / Q000517:prevention & control / Q000628:therapy*; D003362:Cost-Benefit Analysis; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009864:Ontario; D010348:Patient Care Team / Q000191:economics*; D011314:Preventive Health Services / Q000191:economics* / Q000379:methods; D011315:Preventive Medicine / Q000191:economics*; D019035:Rural Health Services / Q000191:economics